Related Experiment Video
Updated: Jan 27, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Anti-Toxoplasma gondii antibodies attach to mouse cancer cell lines but not normal mouse lymphocytes
Fereshteh Mohamadi1, Mahshid Shakibapour1, Seyedeh Maryam Sharafi2
1Department of Medical Parasitology and Mycology, Isfahan University of Medical Sciences, Isfahan 8179498861, Iran.
Abstract:
Toxoplasma gondii (T. gondii) is prevalent intracellular parasite and a cause of worldwide infection in the human population. An inhibitory effect of this parasite on cancer growth has been demonstrated in cell culture and animal models. To determine whether the anticancer activities of T. gondii are associated with host immune response, in the current study the reactivity of anti-T. gondii antiserum with the surface of cancer cell lines was investigated. Anti-T. gondii antibodies were raised in rabbit and the reaction of this antiserum in comparison with other anti-parasite antisera (anti-T. vaginalis, anti-hydatid cyst fluid, anti-protoscolices antigens) with mouse melanoma or breast cancer cells lines was investigated using flow cytometry. Anti-T. gondii antiserum reacted markedly with the surface of mouse melanoma and breast cancer cells, and less so with the normal mouse spleen lymphocytes. Meanwhile, the other anti-parasite antisera did not react strongly with the surface of cancer cells compared with normal mouse spleen lymphocytes. In summary, it has been demonstrated herein that anti-T. gondii antiserum may selectively react with the surface of mouse cancer cells but not with normal mouse spleen lymphocytes. Therefore, further study on anti-Toxoplasma antibodies may be useful for directing the application of selective drug delivery in cancer treatment.
Insights
Toxoplasma gondii (T. gondii) antibodies show selective reactivity with cancer cells, not normal cells. This finding suggests potential for targeted drug delivery in cancer treatment using anti-T. gondii antibodies.
Area of Science:
- Immunology
- Parasitology
- Oncology
Background:
- Toxoplasma gondii (T. gondii) is a widespread intracellular parasite.
- T. gondii exhibits inhibitory effects on cancer growth in preclinical models.
- The role of host immune response in T. gondii's anticancer activity requires further investigation.
Purpose of the Study:
- To investigate the reactivity of anti-T. gondii antiserum with cancer cell surfaces.
- To determine if anti-T. gondii antibodies selectively target cancer cells.
Main Methods:
- Rabbit immunization to generate anti-T. gondii antibodies.
- Flow cytometry analysis of antiserum reactivity with mouse melanoma and breast cancer cell lines.
- Comparison of anti-T. gondii antiserum with other anti-parasite antisera.
Main Results:
- Anti-T. gondii antiserum demonstrated marked reactivity with mouse melanoma and breast cancer cell surfaces.
- The antiserum showed less reactivity with normal mouse spleen lymphocytes.
- Other anti-parasite antisera did not exhibit strong selective reactivity with cancer cells.
Conclusions:
- Anti-T. gondii antiserum selectively reacts with the surface of mouse cancer cells.
- This selective reactivity suggests potential applications for targeted drug delivery in cancer therapy.
- Further research into anti-Toxoplasma antibodies could advance cancer treatment strategies.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cell Lines
Attachment
Attachment Styles
Attachment of Sister Chromatids
Theory of Romantic Attachment in Adulthood

